Radiosurgery Holds Promise for Cancer Patients
Links shared publicly online about this topic.
- 1,866total visits
Radiosurgery Holds Promise for Cancer Patients
pamf.org —
View full resource at pamf.org
Tags: Brain, Cancer, Brain Cancer
Most Recently Shared on July 27, 2009 at 7:09 pm By:
New radiosurgery device treats with 1short session. Targets small area instead of full organ. Patient story: http://tinyurl.com/l3ez67
Vaccine extends life of brain cancer patients - Yahoo! News India
in.news.yahoo.com — “'Vaccine extends life of brain cancer patients' on Yahoo! News India. Washington, April 19 (IANS) A new brain cancer vaccine, which uses material from patients' own tumours, holds promise of extending their lives by several months, show results of a multicentre phase-two clinical trial of the vaccine.” View full resource at in.news.yahoo.com
Most Recently Shared on April 19, 2012 at 1:05 pm By:
Vaccine extends life of brain cancer patients: Washington, April 19 (IANS) A new brain cancer vaccine, which use... http://t.co/Ui9dfsdf
Advanced Melanoma: Using Patients' Own Anti-Tumor Cells Holds Treatment Promise
medicalnewstoday.com — “Results of a small trial published online on 5 March in the Proceedings of the National Academy of Sciences, where patients with progressive metastatic melanoma were treated with billions” View full resource at medicalnewstoday.com
Most Recently Shared on March 7, 2012 at 3:05 pm By:
Advanced Melanoma: Using Patients' Own Anti-Tumor Cells Holds Treatment Promise: Results of a small trial publis... http://t.co/HU8rsuws
Patient's own cells may hold therapeutic promise after reprogramming, gene correction
sciencedaily.com — “Scientists have moved gene therapy one step closer to clinical reality by determining that the process of correcting a genetic defect does not substantially increase the number of potentially cancer-causing mutations in induced pluripotent stem cells.” View full resource at sciencedaily.com
Most Recently Shared on August 2, 2011 at 4:02 pm By:
Pete Shuster Promotional and Health Business Administrator
Patient's own cells may hold therapeutic promise after reprogramming, gene correction: http://t.co/ueKpW46 via @AddThis
New genetic research holds promise for patients with Chuvash polycythemia
news-medical.net — “New research conducted at UNC Lineberger Comprehensive Cancer Center, offers hope for people with a rare disorder called Chuvash polycythemia.” View full resource at news-medical.net
Most Recently Shared on June 23, 2011 at 11:16 am By:
Genetics News: New genetic research holds promise for patients with Chuvash polycythemia: New research conducted... http://bit.ly/kYqnMp
Study shows patient's own cells may hold therapeutic promise after reprogramming, gene correction
labspaces.net — “Scientists from the Morgridge Institute for Research, the University of Wisconsin-Madison, the University of California and the WiCell Research Institute moved gene therapy one step closer to clinical reality by determining that the process of correcting a genetic defect does not substantially increase the number of potentially cancer-causing mutations in induced pluripotent stem cells.” View full resource at labspaces.net
Most Recently Shared on April 5, 2011 at 3:45 pm By:
Study shows patient's own cells may hold therapeutic promise after reprogramming, gene correction - http://is.gd/FtkwSt
Patient--™s Own Cells May Hold Therapeutic Promise After Reprogramming, Gene Correction
newswise.com — “Scientists from the Morgridge Institute for Research, the University of Wisconsin-Madison, the University of California and the WiCell Research Institute moved gene therapy one step closer to clinical reality by determining that the process of correcting a genetic defect does not substantially increase the number of potentially cancer-causing mutations in induced pluripotent stem cells.” View full resource at newswise.com
Most Recently Shared on April 4, 2011 at 7:31 pm By:
newswise Health Communicator and Health News
Patient's Own Cells May Hold Therapeutic Promise After Reprogramming, Gene Correction: Scientists from the Morgr... http://bit.ly/dW1ha2
Cancer drug Gleevec may hold promise against scleroderma: Study
news-medical.net — “A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.” View full resource at news-medical.net
Most Recently Shared on March 28, 2011 at 2:18 pm By:
Cancer drug Gleevec may hold promise against scleroderma: Study: A drug approved to treat certain types of cance... http://bit.ly/eojbMM
Roche Pipeline Gets Lift After Strong RG7204 Skin Cancer Data - FoxBusiness.com
foxbusiness.com — “ZURICH -(Dow Jones)- Swiss drug giant Roche Holding AG (ROG.VX) Wednesday said its promising new skin cancer drug helps patients with advanced forms of the disease live longer and without their illness getting worse, according to late-stage trial data.” View full resource at foxbusiness.com
Most Recently Shared on January 19, 2011 at 11:53 am By:
Roche Pipeline Gets Lift After Strong RG7204 Skin Cancer Data: ZURICH -(Dow Jones)- Swiss drug giant Roche Holdi... http://fxn.ws/e6qPPq
Old Drug Sulfasalazine Holds Promise Against Opportunistic Lung Bug - QualityPoint Technologies
qualitypointtech.net — “A drug to treat inflammation plays a surprising role reducing the level of infection caused by an opportunistic bug that is deadly for AIDS and cancer patients and others with weakened immune systems. The drug, sulfasalazine, spurs the body to get rid of the fungal evaders by enhancing the body's ability to chew them up instead of leaving the debris to litter the lungs, where it would continue to provoke an onslaught of harmful inflammation...” View full resource at qualitypointtech.net
Most Recently Shared on August 21, 2010 at 11:24 am By:
Old Drug Sulfasalazine Holds Promise Against Opportunistic Lung Bug: A drug to treat inflammation plays a surprisi... http://bit.ly/bjC9z0
Old drug holds promise against opportunistic lung bug
physorg.com — “A drug to treat inflammation plays a surprising role reducing the level of infection caused by an opportunistic bug that is deadly for AIDS and cancer patients and others with weakened immune systems.” View full resource at physorg.com
Most Recently Shared on August 19, 2010 at 9:00 pm By:
PhysOrg Health News Health News
Old drug holds promise against opportunistic lung bug http://tw.physorg.com/201428632
Novel nanoparticles prevent radiation damage
eurekalert.org — “Tiny, melanin-covered nanoparticles may protect bone marrow from the harmful effects of radiation therapy, according to scientists at Albert Einstein College of Medicine of Yeshiva University who successfully tested the strategy in mouse models. Infusing these particles into human patients may hold promise in the future. The research is described in the current issue of the International Journal of Radiation, Oncology, Biology, Physics.” View full resource at eurekalert.org
Most Recently Shared on April 29, 2010 at 5:20 pm By:
Melanoma Research Dermatology, Health Organization, and Oncology
@ EurekAlert!: Novel nanoparticles prevent radiation damage. Findings could 1 day help protect cancer patients. Read @ http://bit.ly/aRdUbU
Gemcitabine May Hold Promise for BCG Failures - Renal and Urology News
renalandurologynews.com — “Gemcitabine might be a second-line treatment option for patients with high-risk non-muscle-invasive bladder cancer (BC) who fail therapy with bacille Calmette-Gurin (BCG), according to Italian researchers.” View full resource at renalandurologynews.com
Most Recently Shared on March 30, 2010 at 5:14 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Gemcitabine May Hold Promise for BCG Failures: Gemcitabine might be a second-line treatment option for patients wi... http://bit.ly/cOMQcN
Gemcitabine May Hold Promise for BCG Failures in Bladder Cancer Patients - Renal and Urology News
renalandurologynews.com — “Gemcitabine might be a second-line treatment option for patients with high-risk non-muscle-invasive bladder cancer (BC) who fail therapy with bacille Calmette-Gurin (BCG), according to Italian researchers.” View full resource at renalandurologynews.com
Most Recently Shared on February 25, 2010 at 2:32 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Gemcitabine May Hold Promise for BCG Failures in Bladder Cancer Patients: Gemcitabine might be a second-line treat... http://bit.ly/bgwU3B
Green tea holds hope for prevention of oral cancer
news-medical.net — “Green tea extract has shown promise as cancer prevention agent for oral cancer in patients with a pre-malignant condition known as oral leukoplakia, according to researchers at The University of Texas M. D. Anderson Cancer Center.” View full resource at news-medical.net
Most Recently Shared on November 5, 2009 at 10:16 am By:
News-Medical.Net Oncology and Health News
Oncology News: Green tea holds hope for prevention of oral cancer: Green tea extract has shown pr.. http://bit.ly/2nh1E
ASTRO Use of Radiation Therapy does control skin cancer in certain patient group ...
medicexchange.com — “ASTRO Use of Radiation Therapy does control skin cancer in certain patient group ...” View full resource at medicexchange.com
Most Recently Shared on November 3, 2009 at 9:44 pm By:
Alex van Klaveren Health Social Media
MedicExchange.com ASTRO Radiation Therapy controls skin cancer in patients ... very promising but will it hold up? (http://bit.ly/1fTU2V)
Advertisement
